About Anhua Jinhou
Anhua Jinhou Biotechnology, located in Yiyang City’s Anhua County, specializes in plant extracts and natural product development. From its base in Hunan province, the company operates:
- Two advanced sub-critical extraction production lines
- R&D facilities for medicinal plant research
- Quality control labs for standardized extracts
- Patent-pending extraction processes
Since 2016, the facility has focused on Magnolia officinalis processing, achieving extract purity levels of up to 98% while maintaining environmental standards in China’s traditional tea production region.
Frequently asked questions
Anhua Jinhou Biotechnology provides the following products and services:
- Plant extracts
- Magnolia officinalis extract (Total phenols 2%-98% HPLC)
- Magnolol/Honokiol powder (2%-98% purity)
- Production services
- Sub-critical extraction processing
- Plant active components isolation
- Natural products manufacturing
- R&D services
- Natural products discovery
- Production process development
- Extract standardization
The company operates two production lines with sub-critical extraction equipment.
Anhua Jinhou Biotechnology maintains the following technical infrastructure:
| Category | Capabilities |
|---|---|
| Extraction Technology |
|
| Research Achievement |
|
| Quality Control |
|
Anhua Jinhou Biotechnology operates from the following location:
Main FacilityAnhua County
Yiyang City
Hunan Province
China
The facility includes:
- Production areas
- Two extract production lines
- Sub-critical extraction equipment
- Quality control laboratory
- Research facilities
- R&D laboratory
- Testing facilities
- Process development area
More details about Anhua Jinhou
A leading biotechnology company in Hunan
Anhua Jinhou Biotechnology, established in 2016, operates as a cosmetic lab and research facility in Anhua County, Yiyang City. Located in a region renowned for its dark tea production, the company has built its reputation on innovative plant extraction methods.
Advanced extraction technology and production
The company employs low-temperature sub-critical extraction technology, a method that maintains the integrity of plant active components while minimizing environmental impact. This technology has been successfully implemented for processing Magnolia officinalis, leading to a national invention patent application in 2020.
Production capabilities
The facility houses two dedicated production lines equipped with complete sub-critical extraction systems. These lines produce standardized high-purity plant extracts, including Magnolia officinalis extract with total phenols ranging from 2% to 98% (HPLC) and Magnolol/Honokiol powder.
Research and development services
The company provides:
- Product customization services
- R&D outsourcing for natural products
- Plant active component analysis
- Extraction process optimization
Location and community involvement
Based in Baisha Xi Village, Tianzhuang Township, the company maintains strong ties to the local community. It demonstrates this commitment by allocating 5% of its annual profits to the local public welfare development fund, supporting the region’s growth and development.
Strategic position in Hunan’s biotechnology sector
The location in Hunan province positions the company within China’s growing biotechnology corridor, allowing it to serve both domestic and international markets while maintaining access to local medicinal plant resources.
Company gallery
